Clinuvel Pharmaceuticals
CUV.AX
#8688
Rank
ยฃ0.18 B
Marketcap
ยฃ3.69
Share price
-1.40%
Change (1 day)
-34.51%
Change (1 year)

Revenue for Clinuvel Pharmaceuticals (CUV.AX)

Revenue in 2026: ยฃ48.47 Million

According to Clinuvel Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is ยฃ48.47 Million. In 2026 the company made a revenue of ยฃ48.47 Million an increase over the revenue in the year 2025 that were of ยฃ46.61 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Clinuvel Pharmaceuticals from 2001 to 2026

Annual revenue

Year Revenue Change
2026ยฃ48.47 M3.99%
2025ยฃ46.61 M6.21%
2024ยฃ43.88 M12.75%
2023ยฃ38.92 M15.14%
2022ยฃ33.8 M26.03%
2021ยฃ26.82 M60.04%
2020ยฃ16.76 M3.08%
2019ยฃ16.26 M15.58%
2018ยฃ14.07 M46.97%
2017ยฃ9.57 M177.46%
2016ยฃ3.45 M106.53%
2015ยฃ1.67 M7.98%
2014ยฃ1.54 M46.33%
2013ยฃ1.05 M91.51%
2012ยฃ0.55 M-33.65%
2011ยฃ0.83 M
2010N/A
2009N/A
2008N/A-100%
2007ยฃ0.17 M-57.04%
2006ยฃ0.41 M487.15%
2005ยฃ0.07 M
2004N/A
2002N/A
2001N/A